Enliven Therapeutics Updates Positive Phase 1 Data For ELVN-001 In Chronic Myeloid Leukemia Patients
29/9 05:05
(RTTNews) - Enliven Therapeutics Inc. (ELVN) announced updated, positive data from the Phase 1 clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia who have either failed available therapies, are intolerant to them, or are not candidates for these treatmen...